Richard Purcell

Mr. Purcell has served at RespireRx, since October 2014, as Senior Vice President of Research and Development, in which capacity he is active in clinical operations, research and development, strategic planning and business development. Since 2005, Mr. Purcell has managed DNA Healthlink, Inc., a consulting firm that advises emerging biopharmaceutical and technology companies on new business strategy, operations management, and clinical development of novel compounds. In this capacity, since 2017, he has served as Executive Vice President of Research and Development for Generex Biotechnology Inc. From 2011 to 2017, Mr. Purcell was the President and founder of IntelliSanté, a Healthcare IT startup. Previously, Mr. Purcell was President of ClinPro, Inc., a mid-sized clinical research organization. At ClinPro, Mr. Purcell was responsible for the company’s clinical, business development, strategic planning, sales and IT operations. His significant expertise in designing and executing clinical studies for the marketing of drugs was critical to expanding the company’s operations into the global marketplace. Prior to joining ClinPro, Mr. Purcell worked for SCP Communications, a medical communications company, where he served as Corporate Vice President and General Manager of the Clinical Programs Division, a CRO specializing in Phase IIIb and Phase IV clinical research studies. At SCP, Mr. Purcell designed and managed a number of clinical programs for such drugs as Lipitor, Avandia, Accolate, Meridia, and Tequin. In addition, he participated in the start-up of the number one medical Web site, Medscape, through sales and business development initiatives.